KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

LifeMD (LFMD) Operating Expenses (2016 - 2025)

LifeMD filings provide 14 years of Operating Expenses readings, the most recent being $9.1 million for Q4 2025.

  • On a quarterly basis, Operating Expenses rose 94.92% to $9.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $174.0 million, a 12.58% increase, with the full-year FY2025 number at $174.0 million, up 13.15% from a year prior.
  • Operating Expenses hit $9.1 million in Q4 2025 for LifeMD, down from $54.7 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $55.7 million in Q2 2025 to a low of $4.7 million in Q4 2024.
  • Median Operating Expenses over the past 5 years was $36.6 million (2022), compared with a mean of $37.5 million.
  • Biggest five-year swings in Operating Expenses: skyrocketed 471.52% in 2021 and later plummeted 88.83% in 2024.
  • LifeMD's Operating Expenses stood at $35.5 million in 2021, then fell by 3.07% to $34.4 million in 2022, then increased by 21.07% to $41.7 million in 2023, then plummeted by 88.83% to $4.7 million in 2024, then surged by 94.92% to $9.1 million in 2025.
  • The last three reported values for Operating Expenses were $9.1 million (Q4 2025), $54.7 million (Q3 2025), and $55.7 million (Q2 2025) per Business Quant data.